39,965 Shares in Teladoc Health, Inc. (NYSE:TDOC) Acquired by Vinva Investment Management Ltd

Vinva Investment Management Ltd purchased a new stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 39,965 shares of the health services provider's stock, valued at approximately $363,000.

A number of other institutional investors have also modified their holdings of the business. Versant Capital Management Inc boosted its stake in Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock valued at $29,000 after acquiring an additional 2,441 shares during the period. Whipplewood Advisors LLC acquired a new position in Teladoc Health during the 4th quarter valued at approximately $29,000. Lindbrook Capital LLC grew its stake in Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after buying an additional 1,612 shares during the last quarter. PNC Financial Services Group Inc. increased its position in Teladoc Health by 22.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,978 shares of the health services provider's stock worth $73,000 after buying an additional 1,439 shares during the period. Finally, KBC Group NV lifted its stake in Teladoc Health by 72.3% in the fourth quarter. KBC Group NV now owns 8,849 shares of the health services provider's stock valued at $80,000 after buying an additional 3,714 shares during the last quarter. Institutional investors own 76.82% of the company's stock.

Analyst Ratings Changes

TDOC has been the topic of a number of analyst reports. Bank of America increased their price objective on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a "neutral" rating in a report on Wednesday, February 12th. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a research report on Thursday, February 27th. Royal Bank of Canada lifted their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Oppenheimer lowered their target price on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research note on Friday, January 24th. Finally, The Goldman Sachs Group reduced their price target on shares of Teladoc Health from $16.00 to $13.00 and set a "buy" rating for the company in a research note on Monday, March 3rd. Eleven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $11.26.

Remove Ads

Insider Transactions at Teladoc Health

In related news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. This trade represents a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.95% of the stock is currently owned by insiders.

Teladoc Health Trading Up 0.1 %

NYSE TDOC traded up $0.01 on Wednesday, hitting $8.65. 3,868,278 shares of the company were exchanged, compared to its average volume of 7,793,303. Teladoc Health, Inc. has a twelve month low of $6.76 and a twelve month high of $15.43. The company's 50 day moving average price is $10.39 and its 200-day moving average price is $9.78. The firm has a market capitalization of $1.50 billion, a P/E ratio of -1.50 and a beta of 1.27. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.49 million during the quarter, compared to analysts' expectations of $639.44 million. Analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.